Skip to main content
TipRanks
Go Ultimate75% OFF
Synthesize Bio logo

Synthesize Bio: Valuation, Funding & Investors

Synthesize Bio is a biotechnology company at the forefront of generative genomics, utilizing AI-driven models to simulate gene expression experiments. Their flagship product, Generate Expression Model-1 (GEM-1), is built on an extensive RNA-seq dataset and enables the generation of gene expression data from experimental designs, facilitating drug discovery and scientific research. Founded by scientists from Fred Hutchinson Cancer Center, Synthesize Bio aims to transform biopharmaceutical innovation by providing high-fidelity predictive models that enhance laboratory results and accelerate the development of new therapies.

Leadership & Board

Latest Estimated Valuation

Total Amount Raised
$10M
Total Funding Rounds
1
Latest Funding Amount
$10M
Latest Funding Round
Seed Round

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Sep 17, 2025Seed Round$10.00M―

Investors

Investor NameFunding Round
Inner Loop CapitalSeed Round
AI2 IncubatorSeed Round
MadronaSeed Round
Sahsen VenturesSeed Round
Point Field PartnersSeed Round

Similar Companies

A snapshot of private companies similar to Synthesize Bio, helping you discover and navigate related company profiles.

Related News and Analysis